International Patent: HUMANIZED ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS TARGETED TO EGFR

GENEVA, July 27 -- CITY OF HOPE filed a patent application (US2026/011680) for “HUMANIZED ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS TARGETED TO EGFR”. With publication no. WO/2026/156316, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 40/31

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....